Children's Oncology Group blueprint for research: Acute lymphoblastic leukemia

Cure rates for acute lymphoblastic leukemia (ALL), the most common childhood cancer have steadily improved over the past five decades. This is due to intensifying systemic therapy, recognizing and treating the central nervous system as a sanctuary site, and implementing modern risk stratification to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric blood & cancer 2023-09, Vol.70 (S6), p.e30585-n/a
Hauptverfasser:	Raetz, Elizabeth A., Bhojwani, Deepa, Devidas, Meenakshi, Gore, Lia, Rabin, Karen R., Tasian, Sarah K., Teachey, David T., Loh, Mignon L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute lymphoblastic leukemia Antineoplastic Combined Chemotherapy Protocols - therapeutic use Central Nervous System Chemotherapy Child Children Clinical trials Hematology Humans Lymphatic leukemia lymphoblastic leukemia Oncology Pediatrics precision medicine Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!